ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 64 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 3.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $542,000 | -0.4% | 164,200 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $544,000 | -1.8% | 164,200 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $554,000 | -8.3% | 164,200 | +4.2% | 0.00% | -50.0% |
| Q1 2020 | $604,000 | -77.7% | 157,600 | -64.8% | 0.01% | -71.4% |
| Q4 2019 | $2,704,000 | -20.1% | 447,600 | 0.0% | 0.03% | -22.2% |
| Q3 2019 | $3,384,000 | -30.4% | 447,600 | +24.7% | 0.04% | +200.0% |
| Q2 2019 | $4,860,000 | +400.0% | 358,800 | +100.0% | 0.01% | +100.0% |
| Q1 2019 | $972,000 | +265.4% | 179,400 | +450.3% | 0.01% | +200.0% |
| Q3 2018 | $266,000 | -16.4% | 32,600 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $318,000 | -3.0% | 32,600 | -13.5% | 0.00% | 0.0% |
| Q1 2018 | $328,000 | +1.9% | 37,700 | -1.8% | 0.00% | 0.0% |
| Q3 2017 | $322,000 | -16.6% | 38,400 | +100.0% | 0.00% | 0.0% |
| Q1 2017 | $386,000 | – | 19,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prentice Capital Management, LP | 390,381 | $1,292,000 | 0.49% |
| ETF MANAGERS GROUP, LLC | 891,025 | $2,949,000 | 0.09% |
| AdvisorShares Investments LLC | 353,009 | $1,168,000 | 0.06% |
| ALGERT GLOBAL LLC | 51,028 | $169,000 | 0.05% |
| Bernardo Wealth Planning LLC | 27,219 | $90,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 31,552 | $104,000 | 0.03% |
| ZEKE CAPITAL ADVISORS, LLC | 49,700 | $165,000 | 0.02% |
| Walleye Capital LLC | 51,554 | $171,000 | 0.02% |
| Dynamic Technology Lab Private Ltd | 19,021 | $63,000 | 0.01% |
| J.W. COLE ADVISORS, INC. | 37,064 | $123,000 | 0.01% |